Clinical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Experimental Research Laboratory of Medical Cytogenetics and Molecular Genetics, Istituto Auxologico Italiano, IRCCS, 20145 Milan, Italy.
Genes (Basel). 2022 Feb 11;13(2):335. doi: 10.3390/genes13020335.
Smith-Magenis syndrome (SMS) is a complex genetic disorder characterized by distinctive physical features, developmental delay, cognitive impairment, and a typical behavioral phenotype. SMS is caused by interstitial 17p11.2 deletions (90%), encompassing multiple genes and including the retinoic acid-induced 1 gene (), or by pathogenic variants in itself (10%). is a dosage-sensitive gene expressed in many tissues and acting as transcriptional regulator. The majority of individuals exhibit a mild-to-moderate range of intellectual disability. The behavioral phenotype includes significant sleep disturbance, stereotypes, maladaptive and self-injurious behaviors. In this review, we summarize current clinical knowledge and therapeutic approaches. We further discuss the common biological background shared with other conditions commonly retained in differential diagnosis.
史密斯-马根尼斯综合征(SMS)是一种复杂的遗传疾病,其特征为独特的身体特征、发育迟缓、认知障碍和典型的行为表现。SMS 是由 17p11.2 号染色体间的缺失(90%)引起的,该缺失区域包含多个基因,其中包括视黄酸诱导基因 1 (),或者是由 基因(10%)中的致病性变异引起的。是一种在许多组织中表达的剂量敏感基因,作为转录调节剂。大多数患者表现出轻度至中度的智力障碍。行为表现包括严重的睡眠障碍、刻板行为、适应不良和自伤行为。在这篇综述中,我们总结了目前的临床知识和治疗方法。我们进一步讨论了与其他在鉴别诊断中经常保留的疾病共享的常见生物学背景。